{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:31:16Z","timestamp":1790238676134,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jagp.2018.09.005","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T16:50:29Z","timestamp":1536943829000},"page":"73-83","source":"Crossref","is-referenced-by-count":1,"title":["Trajectories of Antipsychotic Drug Use Over 10 Years in a French Community-Based Sample of Persons Aged 50 and Older"],"prefix":"10.1016","volume":"27","author":[{"given":"H\u00e9l\u00e8ne","family":"Verdoux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Pambrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Cortaredona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Verger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2018.09.005_bib0001","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0447.2009.01425.x","article-title":"Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies","volume":"121","author":"Verdoux","year":"2010","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jagp.2018.09.005_bib0002","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/archgenpsychiatry.2012.647","article-title":"National trends in the office-based treatment of children, adolescents, and adults with antipsychotics","volume":"69","author":"Olfson","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"suppl 2","key":"10.1016\/j.jagp.2018.09.005_bib0003","first-page":"5","article-title":"Using antipsychotic agents in older patients","volume":"65","author":"Alexopoulos","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jagp.2018.09.005_bib0004","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2288-12-72","article-title":"Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review","volume":"12","author":"Pratt","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jagp.2018.09.005_bib0005","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1001\/archinternmed.2012.28","article-title":"Antipsychotic use and myocardial infarction in older patients with treated dementia","volume":"172","author":"Pariente","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jagp.2018.09.005_bib0006","doi-asserted-by":"crossref","first-page":"a1227","DOI":"10.1136\/bmj.a1227","article-title":"Exposure to antipsychotics and risk of stroke: self controlled case series study","volume":"337","author":"Douglas","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jagp.2018.09.005_bib0007","doi-asserted-by":"crossref","first-page":"418","DOI":"10.7326\/0003-4819-152-7-201004060-00006","article-title":"Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case-control study","volume":"152","author":"Trifiro","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jagp.2018.09.005_bib0008","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jamainternmed.2014.6930","article-title":"Falls and fractures with atypical antipsychotic medication use: a population-based cohort study","volume":"175","author":"Fraser","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jagp.2018.09.005_bib0009","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1176\/appi.ajp.2011.08121844","article-title":"Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD","volume":"168","author":"Vigen","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2018.09.005_bib0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2165\/11588470-000000000-00000","article-title":"Risk of hospitalization for hip fracture and pneumonia associated with antipsychotic prescribing in the elderly: a self-controlled case-series analysis in an Australian health care claims database","volume":"34","author":"Pratt","year":"2011","journal-title":"Drug Saf"},{"key":"10.1016\/j.jagp.2018.09.005_bib0011","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/YIC.0000000000000181","article-title":"Trends and factors associated with antipsychotic use among elderly patients with dementia in Taiwan from 2005 to 2013: a population-based study","volume":"32","author":"Chiu","year":"2017","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.jagp.2018.09.005_bib0012","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archgenpsychiatry.2010.200","article-title":"Trends in antipsychotic use in dementia 1999\u20132007","volume":"68","author":"Kales","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jagp.2018.09.005_bib0013","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.euroneuro.2013.09.003","article-title":"Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings","volume":"24","author":"Gallini","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jagp.2018.09.005_bib0014","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40801-016-0073-6","article-title":"Persistence of antipsychotic treatment in elderly dementia patients: a retrospective, population-based cohort study","volume":"3","author":"Mast","year":"2016","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.jagp.2018.09.005_bib0015","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa052827","article-title":"Risk of death in elderly users of conventional vs","volume":"353","author":"Wang","year":"2005","journal-title":"atypical antipsychotic medications. N Engl J Med"},{"key":"10.1016\/j.jagp.2018.09.005_bib0016","doi-asserted-by":"crossref","first-page":"e977","DOI":"10.1136\/bmj.e977","article-title":"Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study","volume":"344","author":"Huybrechts","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jagp.2018.09.005_bib0017","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11336-004-1261-y","article-title":"Causal inferences with group based trajectory models","volume":"70","author":"Haviland","year":"2005","journal-title":"Psychometrika"},{"key":"10.1016\/j.jagp.2018.09.005_bib0018","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/acps.12858","article-title":"Trajectory analysis of anxiolytic dispensing over 10 years among new users aged 50 and older","volume":"137","author":"Verger","year":"2018","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jagp.2018.09.005_bib0019","author":"World Health"},{"key":"10.1016\/j.jagp.2018.09.005_bib0020","article-title":"La politique du m\u00e9dicament en EHPAD","author":"Verger","year":"2013","journal-title":"Ministere des Affaires Sociales et de la Sant\u00e9"},{"key":"10.1016\/j.jagp.2018.09.005_bib0021","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/acps.12344","article-title":"Clozapine use pattern in persons with and without treatment for Parkinson's disease in real-world conditions: a naturalistic study in a community-based sample","volume":"130","author":"Verdoux","year":"2014","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jagp.2018.09.005_bib0022","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1186\/1471-2458-13-1030","article-title":"Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications","volume":"13","author":"Huber","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jagp.2018.09.005_bib0023","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/pds.4146","article-title":"Comparison of pharmacy-based and diagnosis-based comorbidity measures from medico-administrative data","volume":"26","author":"Cortaredona","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jagp.2018.09.005_bib0024","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/0049124106292364","article-title":"Advances in group-based trajectory modeling and an SAS procedure for estimating them","volume":"35","author":"Jones","year":"2007","journal-title":"Sociol Methods Res"},{"key":"10.1016\/j.jagp.2018.09.005_bib0025","doi-asserted-by":"crossref","unstructured":"Nagin D: Group-based trajectory modeling: an overview, in Handbook of Quantitative Criminology. Edited by Piquero A, Weisburd D. New York, Springer, 2010, pp 53--67","DOI":"10.1007\/978-0-387-77650-7_4"},{"key":"10.1016\/j.jagp.2018.09.005_bib0026","first-page":"1690","article-title":"What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes","volume":"280","author":"Zhang","year":"1998","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jagp.2018.09.005_bib0027","article-title":"728 000 r\u00e9sidents en \u00e9tablissements d'h\u00e9bergement pour personnes \u00e2g\u00e9es en 2015. Direction de la Recherche, de l'Evaluation et des Statistiques","author":"Mulller","year":"2017","journal-title":"Etudes et Resultats"},{"key":"10.1016\/j.jagp.2018.09.005_bib0028","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jamapsychiatry.2015.0891","article-title":"Evaluation of antipsychotic dose reduction in late-life schizophrenia: a prospective dopamine D2\/3 receptor occupancy study","volume":"72","author":"Graff-Guerrero","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jagp.2018.09.005_bib0029","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000355418","article-title":"Antipsychotic discontinuation in patients with dementia: a systematic review and meta-analysis of published randomized controlled studies","volume":"37","author":"Pan","year":"2014","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jagp.2018.09.005_bib0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/wps.20420","article-title":"Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls","volume":"16","author":"Correll","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jagp.2018.09.005_bib0031","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4088\/JCP.11m07614","article-title":"Gender differences in clinical manifestations and outcomes among hospitalized patients with behavioral and psychological symptoms of dementia","volume":"73","author":"Kitamura","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jagp.2018.09.005_bib0032","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000080126","article-title":"Undiagnosed diseases in patients with dementia\u2014a potential target group for intervention","volume":"18","author":"Lopponen","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jagp.2018.09.005_bib0033","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jagp.2018.09.005_bib0034","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/JGP.0b013e3181b7ef6e","article-title":"Risk of death related to psychotropic drug use in older people during the European 2003 heatwave: a population-based case-control study","volume":"17","author":"Nordon","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2018.09.005_bib0035","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.euroneuro.2016.07.006","article-title":"Comparative risk of death in older adults treated with antipsychotics: a population-based cohort study","volume":"26","author":"Schmedt","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jagp.2018.09.005_bib0036","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jagp.2017.10.011","article-title":"Psychosis and clinical outcomes in Alzheimer disease: a longitudinal study","volume":"26","author":"Connors","year":"2018","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2018.09.005_bib0037","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00002512-200926060-00006","article-title":"Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis","volume":"26","author":"Jyrkka","year":"2009","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jagp.2018.09.005_bib0038","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/gps.4452","article-title":"Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA","volume":"32","author":"Maust","year":"2017","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2018.09.005_bib0039","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00787-014-0668-y","article-title":"Antipsychotic prescribing in youths: a French community-based study from 2006 to 2013","volume":"24","author":"Verdoux","year":"2015","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.jagp.2018.09.005_bib0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/JCP.0b013e31823f6f46","article-title":"Variation in antipsychotic treatment choice across US nursing homes","volume":"32","author":"Huybrechts","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jagp.2018.09.005_bib0041","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jagp.2017.02.013","article-title":"Antipsychotic use and hospitalization among older assisted living residents: does risk vary by frailty status?","volume":"25","author":"Stock","year":"2017","journal-title":"Am J Geriatr Psychiatry"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748118304822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748118304822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T01:43:43Z","timestamp":1544838223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748118304822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1064748118304822"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2018.09.005","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}